Aponetics has received US Patent No. 6,723,567, "Screening method for apoptosis and necrosis." As stated in the abstract, the patent covers a method for determining non-, anti-, or pro-apoptotic and necrotic conditions of cells; newly designed vectors coding for marker proteins, cell lines transfected with such a vector, and a method to assay the non-, pro- or anti-apoptotic or necrotic activity of test compounds.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.